PXMD vs. AMPE, EFTR, ONCSQ, ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, and BFRIW
Should you be buying PaxMedica stock or one of its competitors? The main competitors of PaxMedica include Ampio Pharmaceuticals (AMPE), eFFECTOR Therapeutics (EFTR), OncoSec Medical (ONCSQ), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.
PaxMedica vs.
Ampio Pharmaceuticals (NYSE:AMPE) and PaxMedica (NASDAQ:PXMD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, risk, dividends, profitability, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.
Ampio Pharmaceuticals has a beta of 3.73, meaning that its share price is 273% more volatile than the S&P 500. Comparatively, PaxMedica has a beta of -1.44, meaning that its share price is 244% less volatile than the S&P 500.
PaxMedica received 1 more outperform votes than Ampio Pharmaceuticals when rated by MarketBeat users. Likewise, 100.00% of users gave PaxMedica an outperform vote while only 0.00% of users gave Ampio Pharmaceuticals an outperform vote.
In the previous week, Ampio Pharmaceuticals had 1 more articles in the media than PaxMedica. MarketBeat recorded 1 mentions for Ampio Pharmaceuticals and 0 mentions for PaxMedica. Ampio Pharmaceuticals' average media sentiment score of 0.00 equaled PaxMedica'saverage media sentiment score.
Ampio Pharmaceuticals' return on equity of 0.00% beat PaxMedica's return on equity.
5.7% of Ampio Pharmaceuticals shares are owned by institutional investors. Comparatively, 4.9% of PaxMedica shares are owned by institutional investors. 3.3% of Ampio Pharmaceuticals shares are owned by insiders. Comparatively, 1.0% of PaxMedica shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
Ampio Pharmaceuticals beats PaxMedica on 7 of the 9 factors compared between the two stocks.
Get PaxMedica News Delivered to You Automatically
Sign up to receive the latest news and ratings for PXMD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
PaxMedica Competitors List
Related Companies and Tools
This page (NASDAQ:PXMD) was last updated on 4/20/2025 by MarketBeat.com Staff
